Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-Pocket Expenditure for Generic Drugs
The global pharmaceutical market is valued at approximately $850 billion, of which the US market is valued at over $300 billion. Sales of generic drugs totaled $43 billion in 2010, in the US. Of all the prescriptions dispensed, generics constituted a majority share of 75% in 2010, in the US. The US President has recently pledged to accelerate the availability of generic drugs in the market and ban pay-for-delay agreements. The availability of generic drugs will be enhanced by preventing...
View full press release